JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 365 JPY 0.3% Market Closed
Market Cap: ¥220.2B

P/S

4.6
Current
35%
Cheaper
vs 3-y average of 7.1

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
4.6
=
Market Cap
¥265.6B
/
Revenue
¥47.6B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
4.6
=
Market Cap
¥265.6B
/
Revenue
¥47.6B

Valuation Scenarios

JMDC Inc is trading below its 3-year average

If P/S returns to its 3-Year Average (7.1), the stock would be worth ¥5 152.99 (53% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-76%
Maximum Upside
+123%
Average Upside
10%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 4.6 ¥3 365
0%
3-Year Average 7.1 ¥5 152.99
+53%
5-Year Average 10.3 ¥7 489.08
+123%
Industry Average 2 ¥1 426.19
-58%
Country Average 1.1 ¥800.63
-76%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
¥265.6B
/
Jan 2026
¥47.6B
=
4.6
Current
¥265.6B
/
Mar 2026
¥52B
=
5.1
Forward
¥265.6B
/
Mar 2027
¥61.4B
=
4.3
Forward
¥265.6B
/
Mar 2028
¥72.5B
=
3.7
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
JP
JMDC Inc
TSE:4483
220.2B JPY 4.6 26.8
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 9.7 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.3B USD 8.2 28.9
AU
Pro Medicus Ltd
ASX:PME
14.4B AUD 57.4 60.8
JP
M3 Inc
TSE:2413
1T JPY 3 20.7
SE
Sectra AB
STO:SECT B
50.6B SEK 21.7 94.4
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 4.4 42.9
US
Doximity Inc
NYSE:DOCS
4.6B USD 7.2 19.1
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.1B CNY 8.8 -61.9
P/E Multiple
Earnings Growth PEG
JP
JMDC Inc
TSE:4483
Average P/E: 63.8
26.8
18%
1.5
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
28.9
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
60.8
29%
2.1
JP
M3 Inc
TSE:2413
20.7
16%
1.3
SE
Sectra AB
STO:SECT B
94.4
14%
6.7
US
W
Waystar Holding Corp
NASDAQ:WAY
42.9
55%
0.8
US
Doximity Inc
NYSE:DOCS
19.1
15%
1.3
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -61.9
69%
N/A

Market Distribution

Higher than 90% of companies in Japan
Percentile
90th
Based on 5 249 companies
90th percentile
4.6
Low
0 — 0.7
Typical Range
0.7 — 1.9
High
1.9 —
Distribution Statistics
Japan
Min 0
30th Percentile 0.7
Median 1.1
70th Percentile 1.9
Max 12 107 466

JMDC Inc
Glance View

Market Cap
220.2B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 968.52 JPY
Undervaluation 15%
Intrinsic Value
Price ¥3 365
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett